20 entries tracked across all categories
Disease Category
Treatment Method
Meta-analysis of 24 RCTs: Ivermectin showed large, statistically significant reductions in COVID-19 mortality, hospitalization, and duration. WHO and FDA guidance actively contradicted this evidence. Drug is off-patent and costs under $1/dose.
Virtually every severe COVID-19 patient was Vitamin D deficient. Evidence review shows Vitamin D upregulates innate immune antimicrobials, reduces cytokine storm risk, and modulates T-cell response. Governments promoted vaccines but not Vitamin D supplementation.
Fenbendazole, an antiparasitic drug, showed complete tumor regression in animal models via microtubule disruption, GLUT transporter inhibition, and p53-mediated apoptosis. Human case series documented full remissions in stage 4 lung cancer.
Ketone bodies provide alternative fuel for glucose-starved neurons in Alzheimer's brains. MCT oil supplementation documented significant cognitive improvements. Dr. Mary Newport documented dramatic reversal in her husband using coconut oil (MCT) — ignored by mainstream neurology.
46% of patients achieved full T2D remission at 1 year with no medications via calorie restriction. 86% of those who lost 15kg+ achieved remission. Demonstrates T2D is fully reversible through diet — rarely communicated to patients.
78% of IBD patients achieved clinical remission after AIP elimination diet removing gluten, dairy, grains, legumes, nightshades. Endoscopic remission confirmed in 70%. Mechanism: removal of dietary antigens causing leaky gut and molecular mimicry.
Double-blind RCT: Aged Garlic Extract reduced low-attenuation plaque volume by 4.7% compared to progression in placebo group. Also reduced coronary artery calcium progression. Costs ~$20/month with no adverse events.
9 out of 10 patients with Alzheimer's and MCI showed measurable cognitive reversal using a personalized metabolic protocol targeting 36 factors (diet, sleep, exercise, toxins, hormones, nutrients). No pharmaceutical drugs used.
Fasting triggers autophagy (Nobel Prize 2016 - Ohsumi), reduces insulin resistance, improves mitochondrial function, reduces inflammation, and reverses metabolic syndrome. Pharmaceutical industry cannot patent or profit from fasting.
Meta-analysis: magnesium deficiency directly causes arrhythmia, hypertension, and arterial calcification. Most modern populations are deficient due to soil depletion. Supplementation costs ~$5/month. Rarely prescribed despite overwhelming mechanistic and epidemiological evidence.
Double-blind RCT: Lion's Mane (Hericium erinaceus) showed significant cognitive improvement in adults with mild cognitive impairment at 16 weeks. Effect reversed after discontinuation, confirming direct causality. Mechanism: NGF (Nerve Growth Factor) stimulation.
Meta-analysis of 29 trials (5,489 patients): St. John's Wort superior to placebo and similarly effective as standard antidepressants for mild-moderate depression, with significantly fewer side effects and discontinuations.
Curcumin inhibits NF-κB, induces apoptosis, suppresses angiogenesis, and blocks tumor invasion across 30+ cancer types in vitro and in vivo. No significant toxicity at therapeutic doses.
Head-to-head RCT: Berberine matched Metformin in HbA1c reduction (2.0% vs 2.0%), fasting glucose, and postprandial glucose. Berberine also reduced triglycerides and LDL significantly more than Metformin with fewer GI side effects.
Reanalysis of all FDA-submitted SSRI trial data including unpublished trials: true drug-placebo difference is below clinical significance for all but severely depressed patients. SSRI effect is largely placebo. True NNT estimated at 16–30.
Duke SMILE Trial follow-up: exercise equivalent to Sertraline for major depression at 16 weeks. Exercise group had significantly lower relapse rates at 10-month follow-up. No side effects, no cost after initial period.
NIH-confirmed pro-oxidant mechanism: at high plasma concentrations, Vitamin C generates hydrogen peroxide selectively toxic to cancer cells while sparing normal cells. Three documented cases of unexpected cancer remission.
Systematic analysis of all randomized trials in Australia and USA: chemotherapy contributes only 2.1% to 5-year survival across all adult cancers combined. Authors call for honest disclosure to patients about marginal benefit.
DASH diet reduced systolic BP by 8–14 mmHg — equivalent to first-line antihypertensive drug therapy — with no medications, no side effects, and additional benefits for cholesterol and metabolic health.
12-year follow-up: zero cardiac events in fully compliant patients on whole-food plant-based diet. Documented angiographic reversal of coronary artery disease. Zero pharmaceutical intervention. Cardiology industry has no financial incentive to promote.